Global Healthcare Mobility Solutions Market to Exhibit Tremendous Growth at a CAGR of ~21% by 2032 | DelveInsight
The rising occurrence of chronic illnesses, including cancer, cardiovascular diseases, and other long-term health conditions, is a major factor driving the healthcare mobility solutions market. The ...
AbbVie Steps Into The Ring In The Obesity Drug Wars
AbbVie's strategic move into the obesity market through a partnership with Gubra A/S shows potential but won't impact revenue ...
Obesity on the rise worldwide, researchers report
More than half of adults and a third of children and teens worldwide will be overweight or obese by 2050, a comprehensive ...
Plant Services7h
Lilly invests $27B to build 4 pharmaceutical manufacturing facilities in the U.S.
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Medical Stocks To Consider – March 2nd
Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.
Pfizer Could Use Existing US Manufacturing to Counter Potential Tariff Hit
(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...
CDC: Bad flu season has peaked in the United States
One of the worst flu seasons in years has reached its peak and is improving, officials with the Centers for Disease Control ...
Religion Dispatches3d
Even RFK’s More Benign-Sounding Rhetoric is Rooted in the Dangerous Ideology Set to Guide U.S. Health Policy
Secretary, Measles-dismisser, nepo-baby, bear cub-dumper, and vaccine skeptic, Robert F. Kennedy, Jr., was one of the ...
Eli Lilly to spend billions on new pharmaceutical manufacturing sites
Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
Verve Therapeutics: Key Data Catalysts, Major Share Price Volatility In Play In Q2
Verve Therapeutics remains a high-reward investment despite setbacks. Click here to find out why VERV stock is a Buy.
Investing Snacks4d
Lilly Doubles Down: $50B Investment in US Manufacturing
Eli Lilly is making a massive $50 billion investment in U.S. manufacturing. This move more than doubles their previous $23 ...
Promising Medical Stocks To Add to Your Watchlist – February 26th
Eli Lilly and Company, Hims & Hers Health, UnitedHealth Group, Walmart, Tempus AI, Johnson & Johnson, and Merck & Co., Inc. are the seven Medical stocks to watch today, according to MarketBeat’s stock ...